Keyphrases
Adverse Events
12%
All-affected
12%
Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT)
12%
Belumosudil
100%
Best Overall Response
25%
Clinically Significant
12%
Complete Response
12%
Confidence Interval
25%
Corticosteroid Dose
12%
Corticosteroids
12%
Dose Reduction
12%
Drug Adverse Events
12%
Duration of Response
25%
Failure-free Survival
12%
Follicular T Helper Cells
12%
Graft-versus-host Disease (GvHD)
100%
High Response Rate
12%
Line of Therapy
100%
Non-relapse Mortality
12%
Overall Response Rate
25%
Overall Survival
12%
Promising Treatment
12%
Protein Kinase 2
12%
Registration Trial
12%
Regulatory T Cells
12%
Response Change
12%
Rho-associated
12%
Selective Inhibitor
12%
Symptom Reduction
12%
Symptom Scale
12%
Twice Daily
37%
Medicine and Dentistry
Adverse Event
40%
Chronic Graft Versus Host Disease
100%
Downregulation
20%
Drug Dose Reduction
20%
Failure Free Survival
20%
Hematopoietic Cell
20%
Immunosuppressant
20%
Overall Survival
20%
Protein Kinases
20%
Regulatory T Cell
20%
T Follicular Helper Cell
20%
Transplantation
20%
Upregulation
20%
Immunology and Microbiology
Chronic Graft Versus Host Disease
100%
Downregulation
20%
Drug Dose Reduction
20%
Failure Free Survival
20%
Follicular B Helper T Cells
20%
Hematopoietic Cell
20%
Immunosuppressant
20%
Overall Survival
20%
Regulatory T Cell
20%
STAT3
20%
STAT5
20%
Upregulation
20%
Pharmacology, Toxicology and Pharmaceutical Science
Adverse Event
40%
Chronic Graft Versus Host Disease
100%
Failure Free Survival
20%
Immunosuppressive Agent
20%
Overall Survival
20%
Protein Kinases
20%